计算溶液所需的质量、体积或浓度。
NRX-0492 is an orally active PROTAC-class BTK degrader. NRX-0492 catalyzes BTK ubiquitination and proteasome degradation ( DC 50 ≤ 0.2 nM, DC 90 ≤ 0.5 nM). NRX-0492 inhibits B cell receptor (BCR) mediated signaling, transcription programs, and chemokine secretion. NRX-0492 can bind non-covalently to the BTK binding domain and cereblon , which is an adapter protein in the E3 ubiquitin ligase complex. NRX-0492 consists of a target protein ligand (red part) BTK-IN-40 , an E3 ligase ligand (blue part) Thalidomide 5-fluoride , and a PROTAC linker (black part) (3R)-3-Pyrrolidinemethanol. E3 ubiquitin ligase and linker can form Thalidomide 5-pyrrolidine-CHO ; the active control for the target protein ligand is BTK ligand 12.